Publication

Arthur R, Brasky TM, Crane TE, Felix AS, Kaunitz AM, Shadyab AH, Qi L, Wassertheil-Smoller S, Rohan TE. 2019. Associations of a Healthy Lifestyle Index With the Risks of Endometrial and Ovarian Cancer Among Women in the Women’s Health Initiative Study. Am J Epidemiol. 188:261–273. doi:10.1093/aje/kwy249.

Hogan DE, Tian F, Malm SW, Olivares C, Palos Pacheco R, Simonich MT, Hunjan AS, Tanguay RL, Klimecki WT, Polt R, et al. 2019. Biodegradability and toxicity of monorhamnolipid biosurfactant diastereomers. J Hazard Mater. 364:600–607. doi:10.1016/j.jhazmat.2018.10.050.

Algotar A, Hsu C-H, Sherry Chow HH, Dougherty S, Babiker HM, Marrero D, Abraham I, Kumar R, Ligibel J, Courneya KS, et al. 2019. Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP): Protocol for a Feasibility and Exploratory Efficacy Study in Men on Androgen Deprivation Therapy. JMIR Res Protoc. 8:e12579. doi:10.2196/12579.

Witten ML, Chau B, Sáez E, Boitano S, Clark Lantz R. 2019. Early life inhalation exposure to mine tailings dust affects lung development. Toxicol Appl Pharmacol. 365:124–132. doi:10.1016/j.taap.2019.01.009.

Liang J, Wolsiefer K, Zestcott CA, Chase D, Stone J. 2019 Feb. Implicit bias toward cervical cancer: Provider and training differences. Gynecol Oncol. doi:10.1016/j.ygyno.2019.01.013.

Chipollini J, Garcia-Castaneda J, Rosa AHD la, Cheriyan S, Azizi M, Spiess PE. 2019 Feb. Important surgical concepts and techniques in inguinal lymph node dissection. Curr Opin Urol. doi:10.1097/MOU.0000000000000591.

Thompson HL, Smithey MJ, Uhrlaub JL, Jeftić I, Jergović M, White SE, Currier N, Lang AM, Okoye A, Park B, et al. 2019. Lymph nodes as barriers to T-cell rejuvenation in aging mice and nonhuman primates. Aging Cell. 18:e12865. doi:10.1111/acel.12865.

Hennemeyer C, Khan A, McGregor H, Moffett C, Woodhead G. 2019. Outcomes of Catheter-Directed Therapy Plus Anticoagulation Versus Anticoagulation Alone for Submassive and Massive Pulmonary Embolism. Am J Med. 132:240–246. doi:10.1016/j.amjmed.2018.10.015.

Batai K, Harb-De la Rosa A, Lwin A, Chaus F, Gachupin FC, Price E, Lee BR. 2019. Racial and Ethnic Disparities in Renal Cell Carcinoma: An Analysis of Clinical Characteristics. Clin Genitourin Cancer. 17:e195-e202. doi:10.1016/j.clgc.2018.10.012.

Mandava S, Keerthivasan MB, Martin DR, Altbach MI, Bilgin A. 2019 Feb. Radial streak artifact reduction using phased array beamforming. Magn Reson Med. doi:10.1002/mrm.27689.

Lin KK, Harrell MI, Oza AM, Oaknin A, Ray-Coquard I, Tinker AV, Helman E, Radke MR, Say C, Vo L-T, et al. 2019. Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma. Cancer Discov. 9:210–219. doi:10.1158/2159-8290.CD-18-0715.

Chandana S, Babiker HM, Mahadevan D. 2019. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC). Expert Opin Investig Drugs. 28:161–177. doi:10.1080/13543784.2019.1557145.

Kozák L, Szilágyi Z, Tóth L, Pócsi I, Molnár I. 2019. Tremorgenic and neurotoxic paspaline-derived indole-diterpenes: biosynthetic diversity, threats and applications. Appl Microbiol Biotechnol. 103:1599–1616. doi:10.1007/s00253-018-09594-x.

Romagnolo DF, Donovan MG, Doetschman TC, Selmin OI. 2019. -6 Linoleic Acid Induces Epigenetics Alterations Associated with Colonic Inflammation and Cancer. Nutrients. 11. doi:10.3390/nu11010171.

Garcia DO, Valdez LA, Aceves B, Bell ML, Humphrey K, Hingle M, McEwen M, Hooker SP. 2019. A Gender- and Culturally Sensitive Weight Loss Intervention for Hispanic Men: Results From the Pilot Randomized Controlled Trial. Health Educ Behav. 46:763–772. doi:10.1177/1090198119853011.

Truong DD, Kratz A, Park JG, Barrientos ES, Saini H, Nguyen T, Pockaj B, Mouneimne G, LaBaer J, Nikkhah M. 2019. A Human Organotypic Microfluidic Tumor Model Permits Investigation of the Interplay between Patient-Derived Fibroblasts and Breast Cancer Cells. Cancer Res. 79:3139–3151. doi:10.1158/0008-5472.CAN-18-2293.

Wang M, Knudsen BS, Nagle RB, Rogers GC, Cress AE. 2019 Jan. A method to quantify centrosomes at single-cell level in human normal and cancer tissue. Mol Biol Cell.:mbcE18100651. doi:10.1091/mbc.E18-10-0651.

Segar JM, Reed D, Stopeck A, Livingston RB, Chalasani P. 2019. A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer. Oncologist. 24:1512-e1267. doi:10.1634/theoncologist.2019-0516.

Alnajjar KS, Krylov IS, Negahbani A, Haratipour P, Kashemirov BA, Huang J, Mahmoud M, McKenna CE, Goodman MF, Sweasy JB. 2019. A pre-catalytic non-covalent step governs DNA polymerase β fidelity. Nucleic Acids Res. 47:11839–11849. doi:10.1093/nar/gkz1076.

Weihs KL, McConnell MH, Wiley JF, Crespi CM, Sauer-Zavala S, Stanton AL. 2019. A preventive intervention to modify depression risk targets after breast cancer diagnosis: Design and single-arm pilot study. Psychooncology. 28:880–887. doi:10.1002/pon.5037.

Shroff RT, Kennedy EB, Bachini M, Bekaii-Saab T, Crane C, Edeline J, El-Khoueiry A, Feng M, Katz MHG, Primrose J, et al. 2019. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. J Clin Oncol. 37:1015–1027. doi:10.1200/JCO.18.02178.

Collins-McMillen D, Rak M, Buehler JC, Igarashi-Hayes S, Kamil JP, Moorman NJ, Goodrum F. 2019. Alternative promoters drive human cytomegalovirus reactivation from latency. Proc Natl Acad Sci U S A. 116:17492–17497. doi:10.1073/pnas.1900783116.

Gachupin FC, Garcia CA, Romero MD. 2019. An American Indian Patient Experience. J Health Care Poor Underserved. 30:62–65. doi:10.1353/hpu.2019.0116.

Steele NG, Chakrabarti J, Wang J, Biesiada J, Holokai L, Chang J, Nowacki LM, Hawkins J, Mahe M, Sundaram N, et al. 2019. An Organoid-Based Preclinical Model of Human Gastric Cancer. Cell Mol Gastroenterol Hepatol. 7:161–184. doi:10.1016/j.jcmgh.2018.09.008.

Ali R, Arshad J, Palacio S, Mudad R. 2019. Brigatinib for -positive metastatic non-small-cell lung cancer: design, development and place in therapy. Drug Des Devel Ther. 13:569–580. doi:10.2147/DDDT.S147499.